NCT07583355

Brief Summary

This behavioral intervention study aims to assess physical activity levels and sedentary behavior among individuals with diabetes. It will compare the effectiveness of standard interventions against informational sessions on the benefits of physical activity for achieving changes in behavior and improving quality of life while reducing reliance on healthcare services. Participants will be divided into 3 groups: one receiving standard care from the diabetology service; one attending three theoretical motor counseling sessions; another engaging in three theoretical motor counseling sessions plus practical counseling supervised by kinesiologist. The primary objective is to evaluate physical activity levels at 6 and 12 months post-intervention. Secondary objectives include assessing sedentary time, health status, anthropometric measurements, blood pressure, barriers to engaging in physical activity, motivation levels, dietary habits, readiness for lifestyle changes, perceived quality of life, and functional capacities.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
123

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
19mo left

Started Feb 2025

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Feb 2025Dec 2027

Study Start

First participant enrolled

February 12, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 13, 2026

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Expected
Last Updated

May 13, 2026

Status Verified

May 1, 2026

Enrollment Period

12 months

First QC Date

April 22, 2026

Last Update Submit

May 6, 2026

Conditions

Keywords

diabetes mellitusphysical activitysedentary behaviorexercise intervention

Outcome Measures

Primary Outcomes (1)

  • Total weekly physical activity time

    Total physical activity (PA) time in a week, expressed in min/week. It result from the sum of time spent in moderate-intensity PA + time spent in vigorous-intensity PA + time spent in walking. This measure will be assessed using the International Physical Activity Questionnaire and Actigraphy.

    At the time of enrollment and follow-up (6 and 12 months).

Secondary Outcomes (38)

  • Total weekly walking physical activity time

    At the time of enrollment and follow-up (6 and 12 months).

  • Total weekly moderate physical activity time

    At the time of enrollment and follow-up (6 and 12 months).

  • Total weekly vigorous physical activity time

    At the time of enrollment and follow-up (6 and 12 months).

  • Sedentary time

    At the time of enrollment and follow-up (6 and 12 months).

  • Age

    At the time of enrollment.

  • +33 more secondary outcomes

Study Arms (3)

Group 1 (n = 41)

NO INTERVENTION

Standard care (SC)

Group 2 (n = 41)

EXPERIMENTAL

Standard care + theoretical counseling on physical activity

Behavioral: Theoretical Counseling on Physical Activity (TCPA)

Group 3 (n = 41)

EXPERIMENTAL

Standard care + theoretical counseling on physical activity + practical counseling on physical activity

Behavioral: Theoretical Counseling on Physical Activity (TCPA)Behavioral: Standard Care + Theoretical Counseling on Physical Activity (TCPA) + Practical Counseling on Physical Activity (PCPA)

Interventions

Participant wil be involved in: * Routine assessments: Anthropometric (weight, height, waist circumference) and hematobiochemical parameters (e.g., glycemic and lipid profiles), and systolic and diastolic blood pressure. * General information + administration of the IPAQ, PACE, Barriers, Mediterranean Diet, and Quality of Life questionnaires. * Body Composition Assessment: BMI, fat mass (FM), fat free mass (FFM), muscle mass, total body water (TBW) and basal metabolism rate (BMR). * Non-diagnostic assessment of functional abilities: submaximal tests of strength, muscular endurance, and flexibility. * Only 3 sessions (1 per month) of TCPA: the Kinesiologist will inform the patient about the guidelines and the various types of PA, as well as their dose-dependent effects.

Group 2 (n = 41)Group 3 (n = 41)

Participant wil be involved in: * Routine assessments: Anthropometric (weight, height, waist circumference) and hematobiochemical parameters (e.g., glycemic and lipid profiles), and systolic and diastolic blood pressure. * General information + administration of the IPAQ, PACE, Barriers, Mediterranean Diet, and Quality of Life questionnaires. * Body Composition Assessment: BMI, fat mass (FM), fat free mass (FFM), muscle mass, total body water (TBW) and basal metabolism rate (BMR). * Non-diagnostic assessment of functional abilities: submaximal tests of strength, muscular endurance, and flexibility. * Only 3 sessions (1 per month) of TCPA: the Kinesiologist will inform the patient about the guidelines and the various types of PA, as well as their dose-dependent effects. * PCPA: supervised mixed physical activity program (cardiovascular + resistance) lasting 3 months, with 2 sessions per week.

Group 3 (n = 41)

Eligibility Criteria

Age25 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of T2DM of at least 3 months;
  • age between 25 and 80 years;
  • engagement in insufficient PA (\< 150 minutes per week of moderate-intensity PA, according to WHO guidelines);
  • ability to walk independently;
  • \< BMI (kg/m²) \< 40.

You may not qualify if:

  • the presence of severe cardiovascular, neurological, or musculoskeletal conditions that contraindicate PA;
  • refusal or inability to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diabetes Center of the Section of Endocrinology and Metabolism, University Hospital of Perugia

Perugia, PG, 06156, Italy

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes MellitusMotor ActivitySedentary Behavior

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Carmine G Fanelli, Prof.

CONTACT

Roberto Pippi, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Controlled, Randomized, non-blinded, intervention study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2026

First Posted

May 13, 2026

Study Start

February 12, 2025

Primary Completion

January 23, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

May 13, 2026

Record last verified: 2026-05

Locations